Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.1 USD | +0.58% | +5.46% | +8.93% |
Apr. 26 | Leerink Partners Adjusts Price Target on Universal Health Services to $195 From $192 | MT |
Apr. 26 | Deutsche Bank Adjusts Price Target on Universal Health Services to $208 From $203 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.93% | 11.12B | B- | ||
-14.92% | 84.87B | B- | ||
+13.30% | 83.08B | C+ | ||
+10.92% | 29.4B | C+ | ||
-12.71% | 16.72B | B | ||
-3.06% | 16.4B | A- | ||
-2.63% | 15.04B | A- | ||
-3.97% | 11.88B | A- | ||
-1.42% | 11.88B | A- | ||
-31.75% | 11.86B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UHS Stock
- Ratings Universal Health Services, Inc.